Pharmacovigilence for Retapamulin: Age-stratified Monitoring of Prescribed Use in the European Union.

Trial Profile

Pharmacovigilence for Retapamulin: Age-stratified Monitoring of Prescribed Use in the European Union.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jun 2013

At a glance

  • Drugs Retapamulin (Primary) ; Fusidic acid; Mupirocin
  • Indications Bacterial infections; Impetigo
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Apr 2012 Planned number of patients 1 added as reported by ClinicalTrials.gov.
    • 07 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top